Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Pei-Yuu Yang"'
Autor:
Fuu-Jen Tsai, Pei-Yuu Yang, Chao-Jung Chen, Ju-Pi Li, Te-Mao Li, Jian-Shiun Chiou, Chi-Fung Cheng, Po-Heng Chuang, Ting-Hsu Lin, Chiu-Chu Liao, Shao-Mei Huang, Bo Ban, Wen-Miin Liang, Ying-Ju Lin
Publikováno v:
BMC Complementary Medicine and Therapies, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background Liver cirrhosis is one of the main causes of the morbidity and mortality in liver diseases. Chinese herbal medicine (CHM) has long been used for the clinical treatment of liver diseases. This study was designed to explore the usag
Externí odkaz:
https://doaj.org/article/3d2019ee5a6d425a8c54f326eea03336
Autor:
Cherry Yin-Yi Chang MD, PhD, Pei-Yuu Yang MD, Fuu-Jen Tsai MD, PhD, Te-Mao Li MD, PhD, Jian-Shiun Chiou MS, Chao-Jung Chen PhD, Ting-Hsu Lin MS, Chiu-Chu Liao MS, Shao-Mei Huang MS, Bo Ban MD, PhD, Wen-Miin Liang PhD, Ying-Ju Lin PhD
Publikováno v:
Integrative Cancer Therapies, Vol 18 (2019)
Background: Ovarian cancer is the seventh most commonly diagnosed malignancy worldwide and has the highest mortality rate among all gynecological cancers. Chinese herbal medicine (CHM) is widely applied in Taiwan and has been used in integrated thera
Externí odkaz:
https://doaj.org/article/7cf23443587349d182026fed077558c6
Autor:
Pei-Yuu Yang, Chen-Jei Tai
Publikováno v:
Case Reports in Oncological Medicine, Vol 2017 (2017)
Afatinib (Gilotrif™) is widely used to treat patients with mutant activating epidermal growth factor receptor- (EGFR-) dependent lung adenocarcinoma; however, it has various adverse side effects. Here, we report a patient with afatinib-induced paro
Externí odkaz:
https://doaj.org/article/eab2f45d2f9142c18defd46c0856d532
Autor:
Fuu-Jen Tsai, Pei-Yuu Yang, Chao-Jung Chen, Ju-Pi Li, Te-Mao Li, Jian-Shiun Chiou, Chi-Fung Cheng, Po-Heng Chuang, Ting-Hsu Lin, Chiu-Chu Liao, Huang, Shao-Mei, Ban, Bo, Wen-Miin Liang, Lin, Ying-Ju
Additional file 1 Figure S1. The cumulative incidence of overall mortality in patients with decompensated liver cirrhosis based on Chinese herbal medicine (CHM) usage (before matching). Figure S2. A flow diagram presenting the study participants enro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57ca8007d5aa7d9769a460a3effe06bc
Autor:
Te-Mao Li, Cherry Yin-Yi Chang, Wen Miin Liang, Fuu Jen Tsai, Ting Hsu Lin, Shao Mei Huang, Jian Shiun Chiou, Chao-Jung Chen, Chiu Chu Liao, Bo Ban, Ying Ju Lin, Pei Yuu Yang
Publikováno v:
Integrative Cancer Therapies, Vol 18 (2019)
Integrative Cancer Therapies
Integrative Cancer Therapies
Background: Ovarian cancer is the seventh most commonly diagnosed malignancy worldwide and has the highest mortality rate among all gynecological cancers. Chinese herbal medicine (CHM) is widely applied in Taiwan and has been used in integrated thera
Autor:
Chiu-Chu Liao, Pei-Yuu Yang, Ting-Hsu Lin, Jian-Shiun Chiou, Ying Ju Lin, Te-Mao Li, Chao-Jung Chen, Ju-Pi Li, Bo Ban, Chi-Fung Cheng, Po-Heng Chuang, Fuu Jen Tsai, Wen Miin Liang, Shao-Mei Huang
Publikováno v:
BMC Complementary Medicine and Therapies
BMC Complementary Medicine and Therapies, Vol 20, Iss 1, Pp 1-10 (2020)
BMC Complementary Medicine and Therapies, Vol 20, Iss 1, Pp 1-10 (2020)
Background Liver cirrhosis is one of the main causes of the morbidity and mortality in liver diseases. Chinese herbal medicine (CHM) has long been used for the clinical treatment of liver diseases. This study was designed to explore the usage frequen
Autor:
Chang, Cherry Yin-Yi, Pei-Yuu Yang, Fuu-Jen Tsai, Te-Mao Li, Jian-Shiun Chiou, Chao-Jung Chen, Ting-Hsu Lin, Chiu-Chu Liao, Huang, Shao-Mei, Ban, Bo, Wen-Miin Liang, Lin, Ying-Ju
Supplemental material, Supplementary_Materials_08122019 for Integrated Chinese Herbal Medicine Therapy Improves the Survival of Patients With Ovarian Cancer by Cherry Yin-Yi Chang, Pei-Yuu Yang, Fuu-Jen Tsai, Te-Mao Li, Jian-Shiun Chiou, Chao-Jung Ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cc19e93e1acdf49433c55f89f52e986